Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems.
| Revenue (Most Recent Fiscal Year) | $446.55M |
| Net Income (Most Recent Fiscal Year) | $-15.55M |
| PE Ratio (Current Year Earnings Estimate) | 155.00 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.34 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.25 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -0.47% |
| Net Margin (Trailing 12 Months) | 0.14% |
| Return on Equity (Trailing 12 Months) | 1.46% |
| Return on Assets (Trailing 12 Months) | 0.14% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.62 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.88 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 3.51 |
| Inventory Turnover (Trailing 12 Months) | 2.06 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.45 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.01 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.16 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.00 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 102.83M |
| Free Float | 98.48M |
| Market Capitalization | $159.39M |
| Average Volume (Last 20 Days) | 0.59M |
| Beta (Past 60 Months) | 1.30 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.23% |
| Percentage Held By Institutions (Latest 13F Reports) | 64.08% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |